Lifeway Foods® Announces Record-Breaking Results for the First Quarter Ended March 31, 2026
Achieves
Record-breaking results signal robust Kefir & Farmer Cheese growth, supported by the widening consumer focus on protein-rich, probiotic foods
Significant gross profit margin expansion of 360 basis points and net income growth of 32% reflect the Company's disciplined operational execution
"We kicked off 2026 with a blowout quarter that demonstrates the extraordinary momentum we've built across our business," said
First Quarter 2026 Highlights
-
Net Sales :$63.0 million , up 36.7% year-over-year. - Gross Profit Margin: 27.5%, up 360 basis points from 23.9% last year.
- Selling, general and administrative expenses were
$10.9 million , up 16.8% from last year, reflecting continued investment in marketing and brand awareness. - Net Income:
$4.7 million , or$0.31 per basic and$0.30 per diluted common share, compared to a net income of$3.5 million , or$0.23 per basic and diluted common share in the prior year.
Expanding Lifeway Visibility
Lifeway recently announced strategic partnerships, experiential marketing initiatives, and product innovation designed to elevate the brand's visibility and engage health-conscious consumers nationwide.
- The Company partnered with Erewhon to launch the Tropical Lifeway Smoothie, made with Organic Lifeway Kefir, offering the ultimate summer refreshment reminiscent of a creamy frozen lemonade while delivering the added benefits of probiotics and protein.
-
The Company hosted a retro-inspired Wellness House in
Palm Springs during festival weekend, bringing together media, influencers, tastemakers and wellness enthusiasts for a celebration of Lifeway's legacy and continued role in shaping the modern wellness conversation. - The Company celebrated forty years of Kefir leadership with new cultured dairy innovations at Expo West 2026, showcasing its Lifeway Muscle Mates™ and Lifeway Kefir Butter™.
Outlook
The Company reiterated its long-term target of $45–$50 million in Adjusted EBITDA1 for FY 2027 and believes it is well positioned to deliver the strongest annual sales in Company history in FY 2026.
"Our momentum continues to build as we drive sustainable, profitable growth across the business," Smolyansky concluded. "We have laid a foundation for durable, long-term value creation, and believe the investments we are making today in manufacturing capacity, marketing and innovation position us exceptionally well to capitalize on the tremendous opportunities ahead."
- Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is defined as Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation.
Conference Call and Webcast
A webcast with Lifeway's President and Chief Executive Officer discussing these results with additional comments and details is available through the "Investor Relations" section of the Company's website at https://lifewaykefir.com/webinars-reports/.
About
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, unaudited estimated net sales. These statements use words, and variations of words, such as "anticipate," "plan," "project," "estimate," "potential," "forecast," "will," "continue," "future," "increase," "believe," "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Lifeway expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.
Non-GAAP Financial Measures
This press release refers to Adjusted EBITDA, which is a financial measure that has not been prepared in accordance with
We are unable to reconcile our target fiscal year 2027 Adjusted EBITDA to projected net income, the most directly comparable projected GAAP financial measure, because certain information necessary to calculate such measures on a GAAP basis is unavailable or dependent on the timing of future events outside of our control. Due to this uncertainty, the Company cannot reconcile target fiscal year 2027 Adjusted EBITDA to the nearest GAAP financial measure without unreasonable effort.
Vice President of Communications,
Email: derekm@lifeway.net
Email: dtarman@perceptualadvisors.com
General inquiries:
Phone: 847-967-1010
Email: info@lifeway.net
|
|
||||||||
|
|
||||||||
|
|
|
|
|
|
||||
|
|
|
(Unaudited) |
|
2025 |
||||
|
Current assets |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
5,604 |
|
|
$ |
5,571 |
|
|
Accounts receivable, net of allowance for credit losses and discounts & allowances of |
|
|
22,985 |
|
|
|
16,643 |
|
|
Inventories, net |
|
|
11,452 |
|
|
|
11,890 |
|
|
Prepaid expenses and other current assets |
|
|
2,588 |
|
|
|
2,627 |
|
|
Refundable income taxes |
|
|
41 |
|
|
|
325 |
|
|
Total current assets |
|
|
42,670 |
|
|
|
37,056 |
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
57,844 |
|
|
|
48,282 |
|
|
Operating lease right-of-use asset |
|
|
553 |
|
|
|
465 |
|
|
|
|
|
11,704 |
|
|
|
11,704 |
|
|
Intangible assets, net |
|
|
5,683 |
|
|
|
5,818 |
|
|
Other assets |
|
|
2,051 |
|
|
|
2,285 |
|
|
Total assets |
|
$ |
120,505 |
|
|
$ |
105,610 |
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
13,845 |
|
|
$ |
11,008 |
|
|
Accrued expenses |
|
|
4,589 |
|
|
|
5,413 |
|
|
Accrued income taxes |
|
|
1,518 |
|
|
|
218 |
|
|
Total current liabilities |
|
|
19,952 |
|
|
|
16,639 |
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit |
|
|
6,939 |
|
|
|
– |
|
|
Operating lease liabilities |
|
|
426 |
|
|
|
360 |
|
|
Deferred income taxes, net |
|
|
2,792 |
|
|
|
2,792 |
|
|
Other long-term liabilities |
|
|
74 |
|
|
|
– |
|
|
Total liabilities |
|
|
30,183 |
|
|
|
19,791 |
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 9) |
|
|
– |
|
|
|
– |
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity |
|
|
|
|
|
|
|
|
|
Preferred stock, no par value; 2,500 shares authorized; none issued |
|
|
– |
|
|
|
– |
|
|
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,282 and |
|
|
6,509 |
|
|
|
6,509 |
|
|
|
|
|
(12,889) |
|
|
|
(13,214) |
|
|
Paid-in capital |
|
|
3,347 |
|
|
|
3,843 |
|
|
Retained earnings |
|
|
93,355 |
|
|
|
88,681 |
|
|
Total stockholders' equity |
|
|
90,322 |
|
|
|
85,819 |
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity |
|
$ |
120,505 |
|
|
$ |
105,610 |
|
|
|
||||||||
|
|
||||||||
|
|
|
2026 |
|
2025 |
||||
|
|
|
|
|
|
||||
|
|
|
$ |
63,012 |
|
|
$ |
46,091 |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold |
|
|
44,741 |
|
|
|
34,254 |
|
|
Depreciation expense |
|
|
920 |
|
|
|
802 |
|
|
Total cost of goods sold |
|
|
45,661 |
|
|
|
35,056 |
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
17,351 |
|
|
|
11,035 |
|
|
|
|
|
|
|
|
|
|
|
|
Selling expense |
|
|
6,188 |
|
|
|
4,698 |
|
|
General and administrative expense |
|
|
4,703 |
|
|
|
4,628 |
|
|
Amortization expense |
|
|
135 |
|
|
|
135 |
|
|
Total operating expenses |
|
|
11,026 |
|
|
|
9,461 |
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
6,325 |
|
|
|
1,574 |
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(68) |
|
|
|
(14) |
|
|
Gain on sales of investments |
|
|
– |
|
|
|
3,352 |
|
|
Other income (expense), net |
|
|
– |
|
|
|
54 |
|
|
Total other (expense) income |
|
|
(68) |
|
|
|
3,392 |
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
|
|
6,257 |
|
|
|
4,966 |
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
1,583 |
|
|
|
1,426 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
4,674 |
|
|
$ |
3,540 |
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings per common share: |
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.31 |
|
|
$ |
0.23 |
|
|
Diluted |
|
$ |
0.30 |
|
|
$ |
0.23 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
Basic |
|
|
15,257 |
|
|
|
15,134 |
|
|
Diluted |
|
|
15,559 |
|
|
|
15,333 |
|
|
|
||||||||
|
|
||||||||
|
|
|
Three months ended |
||||||
|
|
|
2026 |
|
2025 |
||||
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
4,674 |
|
|
$ |
3,540 |
|
|
Adjustments to reconcile net income to operating cash flow: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
1,055 |
|
|
|
937 |
|
|
Stock-based compensation |
|
|
548 |
|
|
|
326 |
|
|
Non-cash interest expense |
|
|
5 |
|
|
|
3 |
|
|
Bad debt expense |
|
|
87 |
|
|
|
– |
|
|
Gain on sale of investments |
|
|
– |
|
|
|
(3,352) |
|
|
Fair value loss on investment |
|
|
– |
|
|
|
20 |
|
|
(Increase) decrease in operating assets: |
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(6,429) |
|
|
|
(1,259) |
|
|
Inventories |
|
|
438 |
|
|
|
(563) |
|
|
Prepaid expenses and other current assets |
|
|
228 |
|
|
|
136 |
|
|
Refundable income taxes |
|
|
283 |
|
|
|
631 |
|
|
Increase (decrease) in operating liabilities: |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
3,397 |
|
|
|
1,401 |
|
|
Accrued expenses |
|
|
(1,282) |
|
|
|
(2,765) |
|
|
Accrued income taxes |
|
|
1,300 |
|
|
|
795 |
|
|
Other long-term liabilities |
|
|
74 |
|
|
|
– |
|
|
Net cash provided by (used in) operating activities |
|
|
4,378 |
|
|
|
(150) |
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(11,041) |
|
|
|
(2,219) |
|
|
Proceeds from sale of investments |
|
|
– |
|
|
|
5,152 |
|
|
Net cash (used in) provided by investing activities |
|
|
(11,041) |
|
|
|
2,933 |
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
Borrowings under line of credit |
|
|
8,000 |
|
|
|
– |
|
|
Repayments under line of credit |
|
|
(1,000) |
|
|
|
– |
|
|
Payment of deferred financing costs |
|
|
(21) |
|
|
|
(65) |
|
|
Equity award settled in cash |
|
|
(283) |
|
|
|
– |
|
|
Net cash provided by (used in) financing activities |
|
|
6,696 |
|
|
|
(65) |
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents |
|
|
33 |
|
|
|
2,718 |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the beginning of the period |
|
|
5,571 |
|
|
|
16,728 |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the end of the period |
|
$ |
5,604 |
|
|
$ |
19,446 |
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information: |
|
|
|
|
|
|
|
|
|
Cash paid for income taxes, net of (refunds) |
|
$ |
– |
|
|
$ |
– |
|
|
Cash paid for interest |
|
$ |
45 |
|
|
$ |
11 |
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash investing activities |
|
|
|
|
|
|
|
|
|
Accrued purchase of property and equipment |
|
$ |
216 |
|
|
$ |
239 |
|
|
Right-of-use assets obtained in exchange for lease obligations |
|
$ |
119 |
|
|
$ |
8 |
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-announces-record-breaking-results-for-the-first-quarter-ended-march-31-2026-302771741.html
SOURCE